Clinical Trial Update: Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments

View source ↗

Summary

This clinical trial listing from National Taiwan University Hospital describes a 24-week interferon-α with ribavirin treatment for chronic hepatitis C, with cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon (interferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis C | Status: UNKNOWN